Saina Nehwal reflects on her career, pain battles, life beyond badminton and why Indian women’s singles is struggling to ...
Cynata is preparing for two trial readouts in 2026 in knee osteoarthritis and acute graft-versus-host disease.
Knee injuries are common in athletes, accounting for 41% of all athletic injuries. But knee injuries aren’t limited to ...
Voyxact, an APRIL inhibitor, receives FDA accelerated approval for adults with primary IgA nephropathy to reduce proteinuria.
The FDA approved Itvisma gene therapy for patients aged 2 years and older with spinal muscular atrophy and confirmed SMN1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback